EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Nanoparticles for Drug Delivery: Design, Mechanisms, and Clinical Translation

Subin Antony Jose, Benjamin Crutchfield, Mario Caballero, Eadrian Carreon, Ian Davis, Pradeep L Menezes iD

Molecules · 06.09.2026 · 31 (17) · 3121

DOI: 10.3390/molecules31173121 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 06.09.2026. Verfasst von Subin Antony Jose und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Mechanical Engineering, University of Nevada, Reno, NV 89557, USA. Hauptthemen laut MEDLINE: Nanoparticles, Drug Delivery Systems, Nanoparticle Drug Delivery System. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nanoparticle-based drug delivery systems have become an important component of modern nanomedicine, enabling improved drug protection, controlled release, targeted delivery, and the modulation of pharmacokinetic behavior. Their therapeutic performance is governed by physicochemical properties such as size, shape, surface chemistry, and material composition, which influence biological interactions, biodistribution, cellular uptake, and clearance. This review examines major nanoparticle platforms, including polymeric, lipid-based, inorganic, carbon-based, and hybrid systems, together with passive and active targeting and endogenous and externally triggered release strategies. Current and emerging applications in oncology, infectious diseases, central nervous system disorders, gene therapy, and vaccines are discussed alongside theranostic and combination-delivery approaches. Particular emphasis is placed on computational modeling, artificial intelligence, and digital twins for formulation optimization and personalized nanomedicine. Key barriers to clinical translation, including manufacturing scalability, biological variability, limitations of EPR-mediated targeting, regulatory standardization, and long-term safety, are critically evaluated. Finally, emerging directions in sustainable nanomanufacturing and biomimetic delivery are discussed. By integrating biological mechanisms with computational, manufacturing, regulatory, and clinical considerations, this review provides a translational perspective on advancing nanoparticle drug-delivery systems from laboratory development toward clinical implementation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesDrug Delivery SystemsNanoparticle Drug Delivery SystemHumansAnimalsNanomedicineTranslational Research, Biomedical

Stichwörter der Autor:innen

artificial intelligenceclinical translationdrug deliverygreen nanomanufacturingnanomedicinenanoparticlespolymeric nanoparticles

Substanzen

Nanoparticle Drug Delivery System

Autor:innen und Institutionen

  • Department of Mechanical Engineering, University of Nevada, Reno, NV 89557, USA.

ORCID-Profile: Pradeep L Menezes

Zitieren

APA

Antony Jose, S., Crutchfield, B., Caballero, M., Carreon, E., Davis, I., & Menezes, P. L. (2026). Nanoparticles for Drug Delivery: Design, Mechanisms, and Clinical Translation. Molecules, 31(17), 3121. https://doi.org/10.3390/molecules31173121

Vancouver

Antony Jose S, Crutchfield B, Caballero M, Carreon E, Davis I, Menezes PL. Nanoparticles for Drug Delivery: Design, Mechanisms, and Clinical Translation. Molecules. 2026;31(17):3121. doi:10.3390/molecules31173121

BibTeX
@article{AntonyJose2026,
  author = {Antony Jose, Subin and Crutchfield, Benjamin and Caballero, Mario and Carreon, Eadrian and Davis, Ian and Menezes, Pradeep L},
  title = {Nanoparticles for Drug Delivery: Design, Mechanisms, and Clinical Translation},
  journal = {Molecules},
  year = {2026},
  volume = {31},
  number = {17},
  pages = {3121},
  doi = {10.3390/molecules31173121}
}
Kostenlos starten →